RICHMOND, Va. & ST. LOUIS--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (Nasdaq Capital Market: CBTE) and Tripos, Inc. (“Tripos”) (Nasdaq Global Select Market: TRPS) are pleased to announce that they have entered into a definitive agreement providing for the acquisition of all of the outstanding capital stock of Tripos Discovery Research Ltd (“TDR”).
